{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:31:47Z","timestamp":1788982307426,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303246"],"award-info":[{"award-number":["82303246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ50493"],"award-info":[{"award-number":["2025JJ50493"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Research Project of Hunan Provincial Health Commission","award":["W20243173"],"award-info":[{"award-number":["W20243173"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01748-0","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:24:48Z","timestamp":1768868688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value"],"prefix":"10.1186","volume":"21","author":[{"given":"Wenchao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyun","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"9","key":"1748_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4(9):1239\u201357.","journal-title":"Nat Cancer"},{"issue":"3","key":"1748_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.drup.2011.02.004","volume":"14","author":"M Murphy","year":"2011","unstructured":"Murphy M, Stordal B. Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2011;14(3):177\u201390.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"key":"1748_CR3","doi-asserted-by":"publisher","first-page":"1062225","DOI":"10.3389\/fimmu.2022.1062225","volume":"13","author":"M Khan","year":"2022","unstructured":"Khan M, Ai M, Du K, Song J, Wang B, Lin J, Ren A, Chen C, Huang Z, Qiu W, et al. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. Front Immunol. 2022;13:1062225.","journal-title":"Front Immunol"},{"issue":"1","key":"1748_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7150\/ijbs.66839","volume":"19","author":"YK Li","year":"2023","unstructured":"Li YK, Zeng T, Guan Y, Liu J, Liao NC, Wang MJ, Chen KX, Luo XY, Chen CY, Quan FF, et al. Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance. Int J Biol Sci. 2023;19(1):258\u201380.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1748_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41419-025-07571-7","volume":"16","author":"A Gao","year":"2025","unstructured":"Gao A, Zou J, Zeng T, Qin M, Tang X, Yi T, Song G, Zhong J, Zeng Y, Zhou W, et al. IGF2BP3\/ESM1\/KLF10\/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming. Cell Death Dis. 2025;16(1):308.","journal-title":"Cell Death Dis"},{"issue":"17","key":"1748_CR6","doi-asserted-by":"publisher","first-page":"e36897","DOI":"10.1016\/j.heliyon.2024.e36897","volume":"10","author":"W Feng","year":"2024","unstructured":"Feng W, Ting Y, Tang X, Liu D, Zhou WC, Li Y, Shen Z. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells. Heliyon. 2024;10(17):e36897.","journal-title":"Heliyon"},{"issue":"1","key":"1748_CR7","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41598-024-82400-z","volume":"15","author":"J Luo","year":"2025","unstructured":"Luo J, Yi T, Wang Y, Song W, Gao Z, Wang J, Li Y. ESM1 promote proliferation, invasion and angiogenesis via Akt\/mTOR and Ras pathway in kidney renal clear cell carcinoma. Sci Rep. 2025;15(1):4902.","journal-title":"Sci Rep"},{"issue":"1","key":"1748_CR8","doi-asserted-by":"publisher","first-page":"15572","DOI":"10.1038\/s41598-025-00581-7","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Gao A, Zhou W, Tang X, Zeng T, Fan T, Jiang W, Tang M, Ouyang F. Unveiling the protective role of ESM1 in endothelial cell proliferation and lipid reprogramming. Sci Rep. 2025;15(1):15572.","journal-title":"Sci Rep"},{"issue":"1","key":"1748_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H, Zhou W, Gao Q, Tang X, Zhang Q, et al. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent Warburg effect within the hypoxic tumor microenvironment. Mol Cancer. 2024;23(1):94.","journal-title":"Mol Cancer"},{"issue":"1","key":"1748_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","volume":"22","author":"YK Li","year":"2024","unstructured":"Li YK, Gao AB, Zeng T, Liu D, Zhang QF, Ran XM, Tang ZZ, Li Y, Liu J, Zhang T, et al. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1. J Transl Med. 2024;22(1):46.","journal-title":"J Transl Med"},{"key":"1748_CR11","doi-asserted-by":"publisher","first-page":"112461","DOI":"10.1016\/j.intimp.2024.112461","volume":"137","author":"Z Fan","year":"2024","unstructured":"Fan Z, Ye M, Liu D, Zhou W, Zeng T, He S, Li Y. Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8(+) T-cell response by activating the Wnt\/\u03b2-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. Int Immunopharmacol. 2024;137:112461.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1748_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12672-025-02113-1","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Fan T, Qin M, Chen S, Zhou W, Wu P, Yuan Y, Tang X, Zeng T, Fang J, et al. ESM1 suppresses LncRNA GAS5\/miR-23a-3p\/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K\/AKT pathway. Discov Oncol. 2025;16(1):327.","journal-title":"Discov Oncol"},{"issue":"7779","key":"1748_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"1","key":"1748_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41589-024-01680-8","volume":"21","author":"D Zhang","year":"2025","unstructured":"Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh PK, Rimayi CC, Moreno-Yruela C, Xu S, Li G, et al. Lysine L-lactylation is the dominant lactylation isomer induced by Glycolysis. Nat Chem Biol. 2025;21(1):91\u20139.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"1748_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2024.11.005","volume":"37","author":"R Liu","year":"2025","unstructured":"Liu R, Ren X, Park YE, Feng H, Sheng X, Song X, AminiTabrizi R, Shah H, Li L, Zhang Y, et al. Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 2025;37(2):377\u2013e394379.","journal-title":"Cell Metab"},{"key":"1748_CR16","doi-asserted-by":"crossref","unstructured":"Wang S, Huang T, Wu Q, Yuan H, Wu X, Yuan F, Duan T, Taori S, Zhao Y, Snyder NW et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J Clin Invest. 2024;134(22):e176851.","DOI":"10.1172\/JCI176851"},{"issue":"10","key":"1748_CR17","doi-asserted-by":"publisher","first-page":"e2404899122","DOI":"10.1073\/pnas.2404899122","volume":"122","author":"J Gao","year":"2025","unstructured":"Gao J, Liu R, Huang K, Li Z, Sheng X, Chakraborty K, Han C, Zhang D, Becker L, Zhao Y. Dynamic investigation of hypoxia-induced L-lactylation. Proc Natl Acad Sci U S A. 2025;122(10):e2404899122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1748_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C. Lactate: A key regulator of the immune response. Immunity. 2025;58(3):535\u201354.","journal-title":"Immunity"},{"issue":"1","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12672-025-02364-y","volume":"16","author":"T Zhang","year":"2025","unstructured":"Zhang T, Zhou W, Fan T, Yuan Y, Tang X, Zhang Q, Zou J, Li Y. Lactic acid metabolism: gynecological cancer\u2019s achilles\u2019 heel. Discov Oncol. 2025;16(1):657.","journal-title":"Discov Oncol"},{"key":"1748_CR20","doi-asserted-by":"publisher","first-page":"216680","DOI":"10.1016\/j.canlet.2024.216680","volume":"587","author":"X Gao","year":"2024","unstructured":"Gao X, Pang C, Fan Z, Wang Y, Duan Y, Zhan H. Regulation of newly identified lysine lactylation in cancer. Cancer Lett. 2024;587:216680.","journal-title":"Cancer Lett"},{"issue":"1","key":"1748_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, Shen X, Wu Y, Zhang S, Wang X, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5(1):61\u201379.","journal-title":"Nat Metab"},{"issue":"14","key":"1748_CR22","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.devcel.2025.02.016","volume":"60","author":"A Li","year":"2025","unstructured":"Li A, Gong Z, Long Y, Li Y, Liu C, Lu X, Li Q, He X, Lu H, Wu K, et al. Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi\/MEKi-resistant melanoma. Dev Cell. 2025;60(14):1974\u201390. e1911.","journal-title":"Dev Cell"},{"issue":"1","key":"1748_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X, Qin J. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1748_CR24","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, Zhou F. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375\u2013e23922333.","journal-title":"Cell"},{"issue":"1","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13000-016-0494-2","volume":"11","author":"J Smith","year":"2016","unstructured":"Smith J, Robida MD, Acosta K, Vennapusa B, Mistry A, Martin G, Yates A, Hnatyszyn HJ. Quantitative and qualitative characterization of two PD-L1 clones: SP263 and E1L3N. Diagn Pathol. 2016;11(1):44.","journal-title":"Diagn Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01748-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01748-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01748-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:02:52Z","timestamp":1770897772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01748-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01748-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study included 131\u00a0\u00b0C tissue samples from patients with ovarian cancer collected by the Department of Pathology at Zhuzhou Hospital Affiliated with the Xiangya School of Medicine between 2014 and 2024. All sample collection and utilization protocols were reviewed and approved by the Hospital Ethics Committee (#LLYPJ2025004-01), which strictly adhered to the Helsinki Declaration. Enrolled patients provided written informed consent, and the specimen handling procedures complied with the Human Genetic Resources Management Regulations for biobank construction standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}